This circumstantial evidence, together with anti-aging properties of metformin, adds to a case for preventive use in elderly.
This systematic review and meta-analysis found that metformin use, especially long-term use, was associated with lower ND risk. However, because there was substantial heterogeneity among studies, high-quality randomized controlled trials are still needed to confirm this finding.
